HUE059930T2 - Újszerû metilált ciklodextrinek és az elõállításukra szolgáló eljárások - Google Patents

Újszerû metilált ciklodextrinek és az elõállításukra szolgáló eljárások

Info

Publication number
HUE059930T2
HUE059930T2 HUE16794381A HUE16794381A HUE059930T2 HU E059930 T2 HUE059930 T2 HU E059930T2 HU E16794381 A HUE16794381 A HU E16794381A HU E16794381 A HUE16794381 A HU E16794381A HU E059930 T2 HUE059930 T2 HU E059930T2
Authority
HU
Hungary
Prior art keywords
production
methods
methylated cyclodextrins
novel methylated
novel
Prior art date
Application number
HUE16794381A
Other languages
English (en)
Inventor
Xavier Parissaux
Jean-Baptiste Palmieri
Mathias Ibert
Clothilde Buffe
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of HUE059930T2 publication Critical patent/HUE059930T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16—Cyclodextrin; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2201/00—Properties
    • C08L2201/06—Biodegradable
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE16794381A 2015-10-16 2016-10-14 Újszerû metilált ciklodextrinek és az elõállításukra szolgáló eljárások HUE059930T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1559832A FR3042501B1 (fr) 2015-10-16 2015-10-16 Nouvelles cyclodextrines methylees et leurs procedes de preparation

Publications (1)

Publication Number Publication Date
HUE059930T2 true HUE059930T2 (hu) 2023-01-28

Family

ID=55135328

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16794381A HUE059930T2 (hu) 2015-10-16 2016-10-14 Újszerû metilált ciklodextrinek és az elõállításukra szolgáló eljárások

Country Status (8)

Country Link
US (1) US11098135B2 (hu)
EP (1) EP3362487B1 (hu)
CN (1) CN108137714B (hu)
ES (1) ES2927629T3 (hu)
FR (1) FR3042501B1 (hu)
HU (1) HUE059930T2 (hu)
PL (1) PL3362487T3 (hu)
WO (1) WO2017064436A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3622959A1 (en) * 2018-09-17 2020-03-18 Roquette America, Inc. Cyclodextrin for protecting cells upon cryopreservation
CN111111446A (zh) * 2019-12-23 2020-05-08 天津膜天膜科技股份有限公司 膜法分离纯化环糊精及其衍生物
CN112062877B (zh) * 2020-06-09 2021-05-25 北京博诺安科科技有限公司 一种甲基化-β-环糊精及其制备、表征方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651725B2 (ja) * 1985-02-28 1994-07-06 メルシャン株式会社 部分メチル化シクロデキストリン及びその製造方法
JP2651567B2 (ja) * 1986-03-20 1997-09-10 花王株式会社 メチル化β−シクロデキストリン
FR2693728B1 (fr) * 1992-07-17 1994-09-23 Orsan Procédé de fabrication de cyclodextrines partiellement méthylées et composés obtenus.
BE1006873A6 (nl) * 1993-03-26 1995-01-10 Merkus Franciscus W H M Toedieningsformulering voor nasale insuline toediening.
DE4333598A1 (de) * 1993-10-01 1995-04-06 Consortium Elektrochem Ind Verfahren zur Herstellung von alkylierten Cyclodextrin-Derivaten, nach dem Verfahren herstellbare methylierte Cyclodextrin-Derivate und die Verwendung der Produkte
US5712117A (en) * 1995-02-08 1998-01-27 Zymogenetics, Inc. Cytoplasmic antiproteinase-2 and coding sequences
US5935941A (en) 1997-10-24 1999-08-10 Pitha; Josef Alkylations of cyclodextrins leading to derivatives which have a ridgidly extended cavity
MXPA02004743A (es) 1999-11-12 2003-10-14 Roquette Freres Mezclas cristalinas de eteres de metilo parciales de beta-ciclodextrina y compuestos relacionados.
JP2006516642A (ja) 2003-02-03 2006-07-06 シャイア ラボラトリーズ，インコーポレイテッド 薬物製剤およびメチル化シクロデキストリン結晶を用いた送達
CN1282662C (zh) * 2005-05-17 2006-11-01 浙江大学 不定位甲基化β－环糊精的合成工艺
KR101633479B1 (ko) * 2012-02-28 2016-07-08 사이덱스 파마슈티칼스, 인크. 알킬화된 시클로덱스트린 조성물 및 이의 제조 및 사용 방법
FR3014694B1 (fr) * 2013-12-13 2016-11-11 Roquette Freres Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl

Also Published As

Publication number Publication date
ES2927629T3 (es) 2022-11-08
US11098135B2 (en) 2021-08-24
CN108137714A (zh) 2018-06-08
US20180319903A1 (en) 2018-11-08
EP3362487B1 (fr) 2022-07-27
PL3362487T3 (pl) 2022-10-17
WO2017064436A1 (fr) 2017-04-20
FR3042501A1 (fr) 2017-04-21
FR3042501B1 (fr) 2017-11-03
EP3362487A1 (fr) 2018-08-22
CN108137714B (zh) 2021-04-09

Similar Documents

Publication Publication Date Title
EP3286264A4 (en) AEROGELS AND METHODS OF PRODUCING THEM
EP3148729A4 (en) Hydride-coated microparticles and methods for making the same
SG10201802084PA (en) Bendable glass stack assemblies, articles and methods of making the same
EP3167457A4 (en) Targeted isotope production system
EP3103633B8 (en) Molded object and production method therefor
EP3175979A4 (en) Molded object and process for producing same
GB2528959C (en) Encoder, decoder and methods
EP3253709A4 (en) Carbon nanotube structures and methods for production thereof
EP3217988A4 (en) New dextran sulfate
GB201612248D0 (en) New process
GB201603358D0 (en) Nanoparticle production
PL3241646T3 (pl) Linia produkcyjna
GB201613997D0 (en) Self-assembled nanocrystals
GB201720494D0 (en) Graphene production method
ZA201802590B (en) Drainage element and method for the production thereof
GB201515411D0 (en) Substituted materials, process for the production and uses thereof
SG11201700102UA (en) Shape retaining material and method for producing the same
PT3286373T (pt) Métodos para a produção de nanocelulose com alto teor de sólidos
PL3362487T3 (pl) Nowatorskie metylowane cyklodekstryny i sposoby ich otrzymywania
EP3141543B8 (en) Vortioxetine intermediate and synthesis process thereof
PL3448395T3 (pl) Cyklodekstryny jako prokoagulanty
GB201609412D0 (en) Self-sanitising compositions and method for the production thereof
GB201609403D0 (en) Booklet production
EP3238910A4 (en) Blow molding method
EP3558903A4 (en) METHOD